Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Mailman

Josh A. Mailman, Cupertino, CA US

Patent application numberDescriptionPublished
20100002260SYSTEM AND PROCESS FOR TRANSMITTING ELECTRONIC MAIL USING A CONVENTIONAL FACSIMILE DEVICE - This invention relates to a system for combining an electronic mail (email) address or addresses and/or facsimile telephone numbers into a fax message, so that when received by a server the fax document is processed and transmitted as an email attachment to the email addresses or a fax message to the telephone numbers of the intended fax recipients. This allows the user to be able to send faxes and emails from a conventional fax machine or personal computer without having an Internet connection.01-07-2010

Paul A. Mailman, Billerica, MA US

Patent application numberDescriptionPublished
20100087169THREADING TOGETHER MESSAGES WITH MULTIPLE COMMON PARTICIPANTS - In a mobile communications device, a conversation identifier is generated for each of a plurality of messages. Each conversation identifier is generated based on addresses of message participants identified in the message. A request to display a particular message of the multiple messages is received. In response to the request, one or more other messages of the plurality of messages having a same conversation identifier as the particular message are identified based on the generated conversation identifiers. At least two of the one or more other messages are displayed concurrently.04-08-2010

Richard B. Mailman, Hershey, PA US

Patent application numberDescriptionPublished
20110190332DOPAMINE RECEPTOR LIGANDS WITH ENHANCED DURATION OF ACTION - Trans-hexahydrobenzoaphenanthridines of the formula (I) wherein X, Y, R08-04-2011

Richard Bernard Mailman, Chapel Hill, NC US

Patent application numberDescriptionPublished
20100041690Co-Administration of Dopamine-Receptor Binding Compounds - Methods for treating a patient having neurological, psychotic, and psychiatric disorders are described comprising the steps of administering to the patient an effective amount of a partial and/or full dopamine D02-18-2010